FAM225A, a novel lncRNA, has only been proved to accelerate the tumorigenesis and metastasis in nasopharyngeal carcinoma by serving as a ceRNA to interact with miR‐590‐3p/miR‐1275 and increasing TGB3 expression.10 This evidence concerns the gene FAM225A and nasopharyngeal carcinoma.